Merck & Co. (MRK) reported Q3 2026 results on 29 Oct 2026. Earnings per share came in at $2.49, against an analyst average of $2.09, a surprise of +19.3%.
Revenue: $18.1B vs $17.3B expected. The quarter ended on 30 Sep 2026.
The company is valued at about $363.7B.
Figures from Yahoo Finance at the time of writing. Not investment advice.